Folic acid and vitamin B6 may prevent pancreatic cancer

Share This Post

A recent study published in the European Journal of Clinical Nutrition showed that diet may play a key role in preventing pancreatic cancer. The study investigated the link between pancreatic cancer risk and the intake of certain nutrients involved in methyl metabolism.

Zhang Jianjun, MD, associate professor of epidemiology at the Indiana University Fairbanks School of Public Health and senior author of the study, said: “Methylation is critical for DNA synthesis and methylation.” Methylation may be related to tumors. Formation is related to growth. Key nutrients for methyl metabolism include folic acid, vitamins B6 and B12, and methionine. The results showed that participants with the highest intake of folic acid had a 69% reduction in pancreatic cancer risk compared with those with the lowest intake. Vitamin B6 intake alone is not associated with pancreatic risk. However, when two nutrients are taken together, it is of practical significance. Large intake of folic acid and vitamin B6 can reduce the risk of pancreatic cancer by 76%.

The results of this study show that the intake of folic acid and vitamin B6 can help prevent pancreatic cancer. However, the American Cancer Institute (AICR) recommends that you get the nutrients you need from food and does not recommend the use of supplements to prevent cancer. AICR recommends eating a cancer-protective diet rich in folic acid, vitamin B6 and other nutrients to reduce the risk of cancer.

Folic acid is a water-soluble vitamin found in green leafy vegetables, beans, nuts and fruits. Vitamin B6 is present in many foods, including fortified grains, beans, poultry, fish and some vegetables and fruits, especially dark green leafy vegetables, papaya, oranges and cantaloupe.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Gamma Delta T Cell therapy in Malaysia
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Malaysia: A Revolution in Cancer Treatment

Gamma Delta T Cell therapy is revolutionizing cancer treatment by harnessing the immune system’s power. This innovative approach is gaining momentum in Malaysia, a rising medical hub in Southeast Asia. With cutting-edge facilities, cost-effective treatments, and strong government support, Malaysia is advancing this therapy to offer hope to cancer patients. By focusing on research and international collaborations, the country is poised to lead the region in next-generation cancer care.

Gamma Delta T Cell therapy in Sinagpore
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Singapore: A Revolutionary Approach for Late-Stage Cancer Treatment

Gamma Delta (GD) T Cell therapy is revolutionizing stage 4 cancer treatment, offering hope to metastatic cancer patients. At Singapore’s National University Hospital (NUH), the ANGELICA trials harness the unique tumor-targeting abilities of GD T cells. This cutting-edge therapy minimizes side effects, enhances survival rates, and improves quality of life. As a global leader in medical innovation, Singapore positions itself as a premier destination for advanced cancer therapies like GD T Cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy